Lirentelimab (Anti-Siglec-8), 1mg*5

Lirentelimab (Anti-Siglec-8), 1mg*5

Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137), 1mg

Utomilumab (Anti-TNFRSF9 / 4-1BB / CD137), 1mg

Lirentelimab (Anti-Siglec-8), 1mg*25

19.336,31 RON
SKU
SKM_A2619_1mg*25

Lirentelimab (Anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). It can be used for the research of eosinophilic gastritis and duodenitis. MW :150 KD.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Lirentelimab (Anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). It can be used for the research of eosinophilic gastritis and duodenitis. MW :150 KD.